{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:14:00Z","timestamp":1760055240700,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"10-11","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.gcb.2009.07.015","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T05:19:36Z","timestamp":1253164776000},"page":"F36-F43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Un cas d\u2019h\u00e9patite auto-immune"],"prefix":"10.1016","volume":"33","author":[{"given":"O.","family":"Chazouill\u00e8res","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gcb.2009.07.015_bib1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","article-title":"Autoimmune hepatitis: clinical challenges","volume":"120","author":"Manns","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2009.07.015_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/08916930701619227","article-title":"Serum autoantibodies: a road map for the clinical hepatologist","volume":"41","author":"Meda","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.gcb.2009.07.015_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.07.015_bib4","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.gcb.2009.07.015_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.07.015_bib6","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.07.015_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.22438","article-title":"The challenge of diagnosing autoimmune hepatitis: less is more","volume":"48","author":"Choi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.07.015_bib8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1053\/jhep.2001.23316","article-title":"Autoimmune overlap syndromes","volume":"33","author":"Woodward","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.07.015_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O\u2019Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.07.015_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.07.015_bib11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared","volume":"16","author":"Summerskill","year":"1975","journal-title":"Gut"},{"key":"10.1016\/j.gcb.2009.07.015_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0168-8278(02)00214-3","article-title":"Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis","volume":"37","author":"Langley","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.gcb.2009.07.015_bib13","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1016\/S0168-8278(08)60991-5","article-title":"Budesonide 3mg tid is superior to prednisone in combination with azathioprine in the treatment of autoimmune hepatitis","volume":"48","author":"Manns","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.gcb.2009.07.015_bib14","first-page":"376","article-title":"Budesonide 3mg BID in combination with azathioprine as maintenance treatment of autoimmune hepatitis\u00a0\u2013\u00a0Final results of a large multicenter international trial","volume":"48","author":"Manns","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.07.015_bib15","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3748\/wjg.15.1035","article-title":"Update on autoimmune hepatitis","volume":"15","author":"Teufel","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.07.015_bib16","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3748\/wjg.v9.i12.2681","article-title":"Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC","volume":"9","author":"Geier","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.07.015_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/jhep.2003.50266","article-title":"Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis","volume":"38","author":"Hempfling","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.07.015_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0016-5085(81)90126-8","article-title":"Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features","volume":"80","author":"Czaja","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2009.07.015_bib19","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type\u00a01 autoimmune hepatitis","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2009.07.015_bib20","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type\u00a0I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.07.015_bib21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","article-title":"Improving the end point of corticosteroid therapy in type\u00a01 autoimmune hepatitis to reduce the frequency of relapse","volume":"102","author":"Montano-Loza","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.07.015_bib22","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/MCG.0b013e318154af74","article-title":"Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis","volume":"42","author":"Luth","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gcb.2009.07.015_bib23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for long-term maintenance of remission in autoimmune hepatitis","volume":"333","author":"Johnson","year":"1995","journal-title":"N Engl J Med"},{"issue":"12 suppl","key":"10.1016\/j.gcb.2009.07.015_bib24","first-page":"630","article-title":"Treatment strategies for autoimmune hepatitis","volume":"101","author":"Heathcote","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.07.015_bib25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.1840040409","article-title":"Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis","volume":"4","author":"Czaja","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.07.015_bib26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0168-8278(00)00095-7","article-title":"Duration of immunosuppressive therapy in autoimmune hepatitis","volume":"34","author":"Kanzler","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.gcb.2009.07.015_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0676.1987.tb00321.x","article-title":"Malignancies following long-term azathioprine treatment in chronic liver disease. A report from the Copenhagen Study Group for Liver Diseases","volume":"7","author":"Tage-Jensen","year":"1987","journal-title":"Liver"},{"key":"10.1016\/j.gcb.2009.07.015_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gcb.2007.10.003","article-title":"Non hodgkin's lymphoma associated with chronic auto-immune hepatitis treated with azathioprine","volume":"32","author":"Sawadogo","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gcb.2009.07.015_bib29","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1572-0241.2008.01922.x","article-title":"Predictive factors for hepatocellular carcinoma in type\u00a01 autoimmune hepatitis","volume":"103","author":"Montano-Loza","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2009.07.015_bib30","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","article-title":"Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening","volume":"48","author":"Yeoman","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2009.07.015_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/jhep.2002.30991","article-title":"Current and novel immunosuppressive therapy for autoimmune hepatitis","volume":"35","author":"Heneghan","year":"2002","journal-title":"Hepatology"}],"container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832009002553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832009002553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:48:40Z","timestamp":1759974520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399832009002553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":31,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0399832009002553"],"URL":"https:\/\/doi.org\/10.1016\/j.gcb.2009.07.015","relation":{},"ISSN":["0399-8320"],"issn-type":[{"type":"print","value":"0399-8320"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Un cas d\u2019h\u00e9patite auto-immune","name":"articletitle","label":"Article Title"},{"value":"Gastroent\u00e9rologie Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gcb.2009.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}